Advances in drug therapy for systemic lupus erythematosus

por Wallace, Daniel J
Publicado 2010

Clinical impact of biologic therapy in the treatment of SLE

por Wallace, Daniel J
Publicado 2013

COVID-19 in patients with rheumatic disease: finally, a denominator

por Wallace, Daniel J
Publicado 2021

Outcome measures in systemic lupus erythematosus: constructing a meaningful response index from existing clinical trial data

por Forbess, Lindsy, Wallace, Daniel, Ishimori, Mariko, Weisman, Michael
Publicado 2014

Hepcidin: regulation of the master iron regulator

por Rishi, Gautam, Wallace, Daniel F., Subramaniam, V. Nathan
Publicado 2015

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study

por Urowitz, Murray B, Isenberg, David A, Wallace, Daniel J
Publicado 2015

Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays

por Rishi, Gautam, Secondes, Eriza S., Wallace, Daniel F., Subramaniam, V. Nathan
Publicado 2020

In Situ Proximity Ligation Assays Indicate That Hemochromatosis Proteins Hfe and Transferrin Receptor 2 (Tfr2) Do Not Interact

por Rishi, Gautam, Crampton, Emily M., Wallace, Daniel F., Subramaniam, V. Nathan
Publicado 2013

Cluster analysis of longitudinal treatment patterns in patients newly diagnosed with systemic lupus erythematosus in the United States

por Kan, Hong, Nagar, Saurabh, Patel, Jeetvan, Wallace, Daniel J, Molta, Charles
Publicado 2014

Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin

por Goh, Justin B., Wallace, Daniel F., Hong, Wanjin, Nathan Subramaniam, V.
Publicado 2015

Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis

por Hawula, Zachary J., Wallace, Daniel F., Subramaniam, V. Nathan, Rishi, Gautam
Publicado 2019

Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis

por Wallace, Daniel J., Gavin, Igor M., Karpenko, Oleksly, Barkhordar, Farnaz, Gillis, Bruce S.
Publicado 2014

Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products

por Wallace, Daniel J, Silverman, Stuart L, Conklin, John, Barken, Derren, Dervieux, Thierry
Publicado 2016

Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by th...

por Wallace, Daniel J, Tse, Karin, Hanrahan, Leslie, Davies, Rupert, Petri, Michelle A
Publicado 2019

The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overload

por Hawula, Zachary J., Secondes, Eriza S., Wallace, Daniel F., Rishi, Gautam, Subramaniam, V. Nathan
Publicado 2021

Experience of robotic catheter ablation in humans using a novel remotely steerable catheter sheath

por Kanagaratnam, Prapa, Koa-Wing, Michael, Wallace, Daniel T., Goldenberg, Alex S., Peters, Nicholas S., Davies, D. Wyn
Publicado 2008

Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus

por Hagiwara, Audrey M., Moore, Richard E., Wallace, Daniel J., Ishimori, Mariko, Jefferies, Caroline A.
Publicado 2021

Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics

por Huang, Gary, Wallace, Daniel F., Powell, Elizabeth E., Rahman, Tony, Clark, Paul J., Subramaniam, V. Nathan
Publicado 2023

Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty‐Four–Week, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐A...

por Merrill, Joan T., Wallace, Daniel J., Wax, Stephen, Kao, Amy, Fraser, Patricia A., Chang, Peter, Isenberg, David
Publicado 2018

Dysregulated hepcidin response to dietary iron in male mice with reduced Gnpat expression

por Rishi, Gautam, Secondes, Eriza S., Asplett, Kiran, Wallace, Daniel F., Ostini, Lesa, Berger, Johannes, Subramaniam, V. Nathan
Publicado 2020